99 related articles for article (PubMed ID: 15508787)
1. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
Trulson I; Holdenrieder S
Tumour Biol; 2024; 46(s1):S111-S161. PubMed ID: 37927288
[TBL] [Abstract][Full Text] [Related]
3. Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.
Tian K; Li Z; Qin L
Biomed Res Int; 2022; 2022():4119912. PubMed ID: 35937401
[TBL] [Abstract][Full Text] [Related]
4. Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.
Dou X; Lu J; Yu Y; Yi Y; Zhou L
Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
[TBL] [Abstract][Full Text] [Related]
5. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
7. Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis.
Bezel P; Valaperti A; Steiner U; Scholtze D; Wieser S; Vonow-Eisenring M; Widmer A; Kowalski B; Kohler M; Franzen DP
Cancer Immunol Immunother; 2021 Jul; 70(7):1867-1876. PubMed ID: 33394095
[TBL] [Abstract][Full Text] [Related]
8. Correlation Analysis of KCNQ1 Gene Polymorphism with Blood Indexes and Prognosis of Non-Small Cell Lung Cancer.
Xie G; Yang Y; Zeng W; Liu Y; Gui B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345992
[TBL] [Abstract][Full Text] [Related]
9. CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan.
Muley T; Schneider MA; Meister M; Thomas M; Heußel CP; Kriegsmann M; Holdenrieder S; Wehnl B; Rolny V; Mang A; Gerber R; Herth F
Tumour Biol; 2024; 46(s1):S163-S175. PubMed ID: 37840516
[TBL] [Abstract][Full Text] [Related]
10. Nanoporous Glass Integrated in Volumetric Bar-Chart Chip for Point-of-Care Diagnostics of Non-Small Cell Lung Cancer.
Li Y; Xuan J; Song Y; Qi W; He B; Wang P; Qin L
ACS Nano; 2016 Jan; 10(1):1640-7. PubMed ID: 26690745
[TBL] [Abstract][Full Text] [Related]
11. Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations.
Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
[TBL] [Abstract][Full Text] [Related]
12. Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and HE4 tumor markers.
Canki E; Schuurbiers MM; Linders TC; Korse CM; van den Heuvel MM; van Herwaarden AE; van Rossum HH
Tumour Biol; 2024; 46(s1):S15-S25. PubMed ID: 37302060
[TBL] [Abstract][Full Text] [Related]
13. Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer.
Xiong L; Zhu C; Lu Y; Chen M; Li M
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15671-15677. PubMed ID: 37658862
[TBL] [Abstract][Full Text] [Related]
14. A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer "PERFECT" filter system.
Li T; Liu Y; Zhang W; Lin L; Zhang J; Xiong Y; Nie L; Liu X; Li H; Wang W
Theranostics; 2020; 10(14):6517-6529. PubMed ID: 32483467
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers.
Vu HM; Mohammad HB; Nguyen TNC; Lee JH; Do Y; Sung JY; Lee SH; Kim MS
Proteomics Clin Appl; 2023 Sep; 17(5):e2300011. PubMed ID: 36807835
[TBL] [Abstract][Full Text] [Related]
16. Parallel accumulation-serial fragmentation method for in-depth proteomic analysis of bronchoalveolar lavage fluid collected from patients with nonsmall cell lung cancer.
Vu HM; Huh S; Lee JH; Lee SH; Kim MS
Proteomics Clin Appl; 2024 Mar; 18(2):e2300053. PubMed ID: 38295123
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer.
Zhang H; Deng D; Li S; Ren J; Huang W; Liu D; Wang W
Cancer Biol Med; 2023 Dec; 21(3):230-51. PubMed ID: 38164737
[TBL] [Abstract][Full Text] [Related]
18. The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.
Huang R; Meng T; Zha Q; Cheng K; Zhou X; Zheng J; Zhang D; Liu R
Crit Care; 2021 Jul; 25(1):234. PubMed ID: 34217339
[TBL] [Abstract][Full Text] [Related]
19. Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.
Diamandis EP; Bast RC; Gold P; Chu TM; Magnani JL
Clin Chem; 2013 Jan; 59(1):22-31. PubMed ID: 23204222
[No Abstract] [Full Text] [Related]
20. Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids.
Li L; Ye Z; Yang S; Yang H; Jin J; Zhu Y; Tao J; Chen S; Xu J; Liu Y; Liang W; Wang B; Yang M; Huang Q; Chen Z; Li W; Fan JB; Liu D
Clin Epigenetics; 2021 Oct; 13(1):185. PubMed ID: 34620221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
